These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37276599)

  • 101. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
    Swen JJ; van der Wouden CH; Manson LE; Abdullah-Koolmees H; Blagec K; Blagus T; Böhringer S; Cambon-Thomsen A; Cecchin E; Cheung KC; Deneer VH; Dupui M; Ingelman-Sundberg M; Jonsson S; Joefield-Roka C; Just KS; Karlsson MO; Konta L; Koopmann R; Kriek M; Lehr T; Mitropoulou C; Rial-Sebbag E; Rollinson V; Roncato R; Samwald M; Schaeffeler E; Skokou M; Schwab M; Steinberger D; Stingl JC; Tremmel R; Turner RM; van Rhenen MH; Dávila Fajardo CL; Dolžan V; Patrinos GP; Pirmohamed M; Sunder-Plassmann G; Toffoli G; Guchelaar HJ;
    Lancet; 2023 Feb; 401(10374):347-356. PubMed ID: 36739136
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.
    Cavallari LH; Johnson JA
    Cell Rep Med; 2023 May; 4(5):101021. PubMed ID: 37084734
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
    Zhang Z; Wu Y; Tan NC; Jiang Y
    Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.
    Holbrook AM
    Ann Intern Med; 2023 Jun; 176(6):JC70. PubMed ID: 37276599
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials.
    Goulding R; Dawes D; Price M; Wilkie S; Dawes M
    Br J Clin Pharmacol; 2015 Oct; 80(4):868-77. PubMed ID: 25060532
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.
    Cavallari LH; Beitelshees AL; Blake KV; Dressler LG; Duarte JD; Elsey A; Eichmeyer JN; Empey PE; Franciosi JP; Hicks JK; Holmes AM; Jeng L; Lee CR; Lima JJ; Limdi NA; Modlin J; Obeng AO; Petry N; Pratt VM; Skaar TC; Tuteja S; Voora D; Wagner M; Weitzel KW; Wilke RA; Peterson JF; Johnson JA
    Clin Transl Sci; 2017 May; 10(3):143-146. PubMed ID: 28294551
    [No Abstract]   [Full Text] [Related]  

  • 108. A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.
    Plumpton CO; Roberts D; Pirmohamed M; Hughes DA
    Pharmacoeconomics; 2016 Aug; 34(8):771-93. PubMed ID: 26984520
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
    Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
    Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
    Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
    Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
    Shah RR
    Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
    [TBL] [Abstract][Full Text] [Related]  

  • 112. [Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy].
    Rumyantsev NA; Kukes VG; Kazakov RE; Rumyantsev AA; Sychev DA
    Ter Arkh; 2017; 89(1):82-87. PubMed ID: 28252633
    [TBL] [Abstract][Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.